Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells.

Bilmin K, Kujawska T, Grieb P.

Cells. 2019 Nov 13;8(11). pii: E1428. doi: 10.3390/cells8111428. Review.

2.

Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.

Suehiro S, Ohnishi T, Yamashita D, Kohno S, Inoue A, Nishikawa M, Ohue S, Tanaka J, Kunieda T.

J Neurosurg. 2018 Dec 1;129(6):1416-1428. doi: 10.3171/2017.6.JNS162398.

PMID:
29350596
3.

Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas.

Sun Y, Wang H, Wang P, Zhang K, Geng X, Liu Q, Wang X.

Biomater Sci. 2019 Feb 26;7(3):985-994. doi: 10.1039/c8bm01187g.

PMID:
30601475
4.

Porphyrin derivatives-mediated sonodynamic therapy for malignant gliomas in vitro.

Endo S, Kudo N, Yamaguchi S, Sumiyoshi K, Motegi H, Kobayashi H, Terasaka S, Houkin K.

Ultrasound Med Biol. 2015 Sep;41(9):2458-65. doi: 10.1016/j.ultrasmedbio.2015.05.007. Epub 2015 Jun 10.

5.

5-Aminolevulinic acid-mediated sonosensitization of rat RG2 glioma cells in vitro.

Bilmin K, Kujawska T, Secomski W, Nowicki A, Grieb P.

Folia Neuropathol. 2016;54(3):234-240.

6.

MR-guided Focused Ultrasound Facilitates Sonodynamic Therapy with 5-Aminolevulinic Acid in a Rat Glioma Model.

Wu SK, Santos MA, Marcus SL, Hynynen K.

Sci Rep. 2019 Jul 18;9(1):10465. doi: 10.1038/s41598-019-46832-2.

7.

Recent advances of sonodynamic therapy in cancer treatment.

Wan GY, Liu Y, Chen BW, Liu YY, Wang YS, Zhang N.

Cancer Biol Med. 2016 Sep;13(3):325-338.

8.

Natural products in the discovery of novel sonosensitizers.

Pang X, Xu C, Jiang Y, Xiao Q, Leung AW.

Pharmacol Ther. 2016 Jun;162:144-51. doi: 10.1016/j.pharmthera.2015.12.004. Epub 2015 Dec 17. Review.

PMID:
26706240
9.

Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.

Ju D, Yamaguchi F, Zhan G, Higuchi T, Asakura T, Morita A, Orimo H, Hu S.

Tumour Biol. 2016 Aug;37(8):10415-26. doi: 10.1007/s13277-016-4931-3. Epub 2016 Feb 4.

PMID:
26846106
10.

5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.

Hu Z, Fan H, Lv G, Zhou Q, Yang B, Zheng J, Cao W.

J Dermatol Sci. 2015 Aug;79(2):155-62. doi: 10.1016/j.jdermsci.2015.04.010. Epub 2015 May 1.

PMID:
25982144
11.

Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment.

Ma X, Pan H, Yi J.

Med Hypotheses. 2009 Apr;72(4):418-20. doi: 10.1016/j.mehy.2008.10.024. Epub 2009 Jan 6.

PMID:
19128891
12.

Sonodynamic Therapy for Malignant Glioma Using 220-kHz Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound and 5-Aminolevulinic acid.

Yoshida M, Kobayashi H, Terasaka S, Endo S, Yamaguchi S, Motegi H, Itay R, Suzuki S, Brokman O, Shapira Y, Moriyama K, Kawase Y, Akahane T, Kato Y, Kamada H, Houkin K.

Ultrasound Med Biol. 2019 Feb;45(2):526-538. doi: 10.1016/j.ultrasmedbio.2018.10.016. Epub 2018 Dec 4.

PMID:
30522817
13.

Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers.

Trendowski M.

Chemother Res Pract. 2015;2015:316015. doi: 10.1155/2015/316015. Epub 2015 Aug 25. Review.

14.

Effects of 5-aminolevulinic acid-mediated sonodynamic therapy on macrophages.

Cheng J, Sun X, Guo S, Cao W, Chen H, Jin Y, Li B, Li Q, Wang H, Wang Z, Zhou Q, Wang P, Zhang Z, Cao W, Tian Y.

Int J Nanomedicine. 2013;8:669-76. doi: 10.2147/IJN.S39844. Epub 2013 Feb 13.

15.

Sonodynamic therapy consisting of focused ultrasound and a photosensitizer causes a selective antitumor effect in a rat intracranial glioma model.

Nonaka M, Yamamoto M, Yoshino S, Umemura S, Sasaki K, Fukushima T.

Anticancer Res. 2009 Mar;29(3):943-50.

16.

Study of the mechanism of sonodynamic therapy in a rat glioma model.

Song D, Yue W, Li Z, Li J, Zhao J, Zhang N.

Onco Targets Ther. 2014 Sep 30;7:1801-10. doi: 10.2147/OTT.S52426. eCollection 2014.

17.

Sonodynamic therapy improves anti‑tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft.

Peng Y, Jia L, Wang S, Cao W, Zheng J.

Oncol Rep. 2018 Oct;40(4):2163-2170. doi: 10.3892/or.2018.6612. Epub 2018 Aug 1.

PMID:
30106435
18.

Sonodynamic therapy using 5-aminolevulinic acid enhances the efficacy of bleomycin.

Osaki T, Ono M, Uto Y, Ishizuka M, Tanaka T, Yamanaka N, Kurahashi T, Azuma K, Murahata Y, Tsuka T, Ito N, Imagawa T, Okamoto Y.

Ultrasonics. 2016 Apr;67:76-84. doi: 10.1016/j.ultras.2016.01.003. Epub 2016 Jan 12.

PMID:
26799128
19.

Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat.

Ohmura T, Fukushima T, Shibaguchi H, Yoshizawa S, Inoue T, Kuroki M, Sasaki K, Umemura S.

Anticancer Res. 2011 Jul;31(7):2527-33.

PMID:
21873170
20.

Sonodynamic therapy-assisted immunotherapy: A novel modality for cancer treatment.

Zhang Q, Bao C, Cai X, Jin L, Sun L, Lang Y, Li L.

Cancer Sci. 2018 May;109(5):1330-1345. doi: 10.1111/cas.13578. Epub 2018 May 7.

Supplemental Content

Support Center